Megan E. Baldwin

5.9k total citations · 3 hit papers
37 papers, 4.1k citations indexed

About

Megan E. Baldwin is a scholar working on Molecular Biology, Oncology and Ophthalmology. According to data from OpenAlex, Megan E. Baldwin has authored 37 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 17 papers in Oncology and 8 papers in Ophthalmology. Recurrent topics in Megan E. Baldwin's work include Angiogenesis and VEGF in Cancer (29 papers), Lymphatic System and Diseases (16 papers) and Retinal Diseases and Treatments (7 papers). Megan E. Baldwin is often cited by papers focused on Angiogenesis and VEGF in Cancer (29 papers), Lymphatic System and Diseases (16 papers) and Retinal Diseases and Treatments (7 papers). Megan E. Baldwin collaborates with scholars based in Australia, United States and Finland. Megan E. Baldwin's co-authors include Marc G. Achen, Steven A. Stacker, Kari Alitalo, Richard A. Williams, Lotta Jussila, Hajime Kubo, Carol Caesar, Remko Prevo, David G. Jackson and Shin‐Ichi Nishikawa and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and The Journal of Experimental Medicine.

In The Last Decade

Megan E. Baldwin

36 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

VEGF-D promotes the metastatic spread of tumor cells via the lymphatics

2001 993 citations Steven A. Stacker, Carol Caesar et al. Nature Medicine profile →
Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells

2007 673 citations Farbod Shojaei, Xiumin Wu et al. Nature Biotechnology profile →
Lymphangiogenesis and cancer metastasis

2002 647 citations Steven A. Stacker, Marc G. Achen et al. Nature reviews. Cancer profile →

Peers

Megan E. Baldwin

ONCOL

SURGE

PHYSI

Paula Velasco United States

Tanja Veikkola Finland

Katri Pajusola Finland

Eola Kukk Finland

Lotta Jussila Finland

Nathan Bucay United States

Andrew Sullivan United Kingdom

Thomas Hawighorst Germany

Brett M. Hall United States

Athina Lymboussaki Finland

Paula Velasco United States

Megan E. Baldwin

2.6k ×0.9

ONCOL

2.7k ×1.0

656 ×1.0

661 ×1.0

SURGE

469 ×0.9

PHYSI

Citations per year, relative to Megan E. Baldwin Megan E. Baldwin (= 1×) peers Paula Velasco

Countries citing papers authored by Megan E. Baldwin

Since Specialization

Citations

This map shows the geographic impact of Megan E. Baldwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Megan E. Baldwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Megan E. Baldwin more than expected).

Fields of papers citing papers by Megan E. Baldwin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Megan E. Baldwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Megan E. Baldwin. The network helps show where Megan E. Baldwin may publish in the future.

Co-authorship network of co-authors of Megan E. Baldwin

This figure shows the co-authorship network connecting the top 25 collaborators of Megan E. Baldwin. A scholar is included among the top collaborators of Megan E. Baldwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Megan E. Baldwin. Megan E. Baldwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Boyer, David S., Nathan Steinle, Joel Pearlman, et al.. (2024). Phase 1b Dose Escalation Study of Sozinibercept Inhibition of Vascular Endothelial Growth Factors C and D With Aflibercept for Diabetic Macular Edema. Translational Vision Science & Technology. 13(12). 32–32.

Leitch, Ian M., Michael Gerometta, David Eichenbaum, et al.. (2024). Vascular Endothelial Growth Factor C and D Signaling Pathways as Potential Targets for the Treatment of Neovascular Age-Related Macular Degeneration: A Narrative Review. Ophthalmology and Therapy. 13(7). 1857–1875. 8 indexed citations

Jackson, Timothy L., Jason S. Slakter, Marc Buyse, et al.. (2023). A Randomized Controlled Trial of OPT-302, a VEGF-C/D Inhibitor for Neovascular Age-Related Macular Degeneration. Ophthalmology. 130(6). 588–597. 32 indexed citations

Hood, Julia E., Rachel W. Kubiak, Tigran Avoundjian, et al.. (2022). A Multifaceted Evaluation of a COVID-19 Contact Tracing Program in King County, Washington. Journal of Public Health Management and Practice. 28(4). 334–343. 8 indexed citations

Shatos, Marie A., et al.. (2019). VEGF-C and VEGF-D Inhibition by VGX-300 Effectively Reduces Leukocyte Adhesion and Vascular Leakage in the STZ- Rat Model of Diabetic Retinal Edema. Investigative Ophthalmology & Visual Science. 60(9). 3667–3667. 2 indexed citations

Dugel, Pravin U., David S. Boyer, Andrew N. Antoszyk, et al.. (2019). Phase 1 Study of OPT-302 Inhibition of Vascular Endothelial Growth Factors C and D for Neovascular Age-Related Macular Degeneration. Ophthalmology Retina. 4(3). 250–263. 45 indexed citations

Johnson, Walter H., et al.. (2017). Plasma Levels of VEGF-C and Soluble VEGF Receptor-3 are Elevated in Neovascular AMD. Investigative Ophthalmology & Visual Science. 58(8). 2327–2327. 1 indexed citations

Ma, Jie, et al.. (2016). Expression of VEGF-A, VEGF-C, VEGF-D and soluble receptors in Clinical Age-Related Macular Degeneration. Investigative Ophthalmology & Visual Science. 57(12). 3698–3698. 1 indexed citations

Lashkari, Kameran, et al.. (2015). VGX-300, a ‘Trap’ for VEGF-C and VEGF-D, Inhibits Choroidal Neovascularization and Vascular Leakage in a Mouse Model of Wet AMD. Investigative Ophthalmology & Visual Science. 56(7). 4802–4802. 2 indexed citations

10.

Woollard, David J., et al.. (2012). Differential expression of VEGF ligands and receptors in prostate cancer. The Prostate. 73(6). 563–572. 35 indexed citations

11.

Shojaei, Farbod, Xiumin Wu, Ajay K. Malik, et al.. (2007). Tumor refractoriness to anti-VEGF treatment mediated by CD11b+Gr1+ myeloid cells. Molecular Cancer Therapeutics. 6. 1 indexed citations

12.

Shojaei, Farbod, Xiumin Wu, Ajay K. Malik, et al.. (2007). Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells. Nature Biotechnology. 25(8). 911–920. 673 indexed citations breakdown →

13.

Stacker, Steven A., Rae H. Farnsworth, Tara Karnezis, et al.. (2006). Molecular Pathways for Lymphangiogenesis and their Role in Human Disease. Novartis Foundation symposium. 281. 38–49. 16 indexed citations

14.

Baldwin, Megan E., Xiao Huan Liang, Johanna Busch, et al.. (2004). Generation of mice carrying floxed VEGFR-1 and VEGFR-2 alleles to study the effects of postnatal gene ablation on angiogenesis and hematopoiesis. Cancer Research. 64. 596–596. 1 indexed citations

15.

McColl, Bradley, Megan E. Baldwin, Sally Roufail, et al.. (2003). Plasmin Activates the Lymphangiogenic Growth Factors VEGF-C and VEGF-D. The Journal of Experimental Medicine. 198(6). 863–868. 164 indexed citations

16.

Baldwin, Megan E., Steven A. Stacker, & Marc G. Achen. (2002). Molecular control of lymphangiogenesis. BioEssays. 24(11). 1030–1040. 65 indexed citations

17.

Stacker, Steven A., Marc G. Achen, Lotta Jussila, Megan E. Baldwin, & Kari Alitalo. (2002). Lymphangiogenesis and cancer metastasis. Nature reviews. Cancer. 2(8). 573–583. 647 indexed citations breakdown →

18.

Baldwin, Megan E., Sally Roufail, Michael M. Halford, et al.. (2001). Multiple Forms of Mouse Vascular Endothelial Growth Factor-D Are Generated by RNA Splicing and Proteolysis. Journal of Biological Chemistry. 276(47). 44307–44314. 61 indexed citations

19.

Stacker, Steven A., Carol Caesar, Megan E. Baldwin, et al.. (2001). VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nature Medicine. 7(2). 186–191. 993 indexed citations breakdown →

20.

Thorburn, A W, Megan E. Baldwin, Gennaro Rosella, et al.. (1999). Features of syndrome X develop in transgenic rats expressing a non-insulin responsive phosphoenolpyruvate carboxykinase gene. Diabetologia. 42(4). 419–426. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact